Baylor College of Medicine and the Alzheimer’s Association Houston & Southeast Texas Chapter are hosting the annual “Update on Alzheimer’s Disease” lecture, and will feature one of the leading researchers currently working on Alzheimer’s disease, Rachelle Doody. The community of Houston will have the opportunity to hear the specialist lecture today.
Rachelle Doody, a professor of neurology and director of the Alzheimer’s Disease and Memory Disorders Center (ADMDC) at Baylor College of Medicine, is the main host of the educational symposium, which will focus on the latest research regarding the disease. The specialist, who is also the Effie Marie Cain Chair in Alzheimer’s Disease Research at Baylor, will be responsible for presenting the most recent information on research efforts to understand, treat, and cure the disease. After her presentation, Dr. Doody will take questions from attendants.
With more than 30 years of experience, Doody’s research has been focused on the cognitive aspects of Alzheimer’s disease, dementia, and aphasia, as well as on finding therapeutics options, models of progression for clinical prognostication, validation of biological markers, and improving the design of clinical trials for Alzheimer’s. The researcher received her MD/PhD from Baylor College of Medicine, served as an intern in internal medicine at the McGill University Faculty of Medicine in Montreal, and returned to the BCM for her residency in neurology, where she has worked ever since.
Doody recently led a study to evaluate the efficacy of the drug treatment Solanezumab, which had previously revealed positive results in animals with Alzheimer’s. However, her research team discovered that the drug was not able to improve either the cognition or the functional ability of patients with mild to moderate Alzheimer’s disease. Despite the results of the clinical trials, Dr. Doody said that it contributed to better understanding more about the disease, as “the results help us to pinpoint at what stage of the disease this type of drug will be most beneficial.”
The “Update on Alzheimer’s Disease” lecture, for which the registration free and open to the public, is taking place this Monday, November 10, at 6:30 p.m. at the Houston Museum of Natural Science, 5555 Hermann Park Drive, Houston, Texas. The event is partially financed by the Moselle and Milton Pollack Endowed Fund for Alzheimer’s Education in the Alzheimer’s Disease and Memory Disorders Center at Baylor.
The ADMDC is currently one of the few centers in the United States focused on both improving patient care and conducting research, and has been dedicated to the translation of discoveries made in the laboratory into improved methods of disease prevention, diagnosis, and treatment. Internationally recognized for its work, the center contributes to the development and supervision of several of the clinical trials on Alzheimer’s disease or memory disorders worldwide.